Most Read Articles
Roshini Claire Anthony, 2 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Jairia Dela Cruz, 6 days ago
Male smokers under the age of 50 years are at risk of developing ischaemic stroke, and this risk increases with the number of cigarettes smoked daily, according to data from the Stroke Prevention in Young Men Study.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Bright white light therapy improves depression in patients with bipolar disorder

11 Feb 2018

Use of midday bright light therapy is effective in patients with bipolar depression, suggests a study.

A 6-week randomized, double-blind, placebo-controlled trial was conducted to assess the efficacy of adjunctive bright light therapy at midday for bipolar depression. Depressed adults with bipolar I or II disorder who were receiving stable dosages of antimanic medication (excluding those with hypomania or mania, mixed symptoms, or rapid cycling) were randomly assigned to either 7,000-lux bright white light or 50-lux dim red placebo light (n=23 for each group).

The investigators used the Structured Interview Guide for the Hamilton Depression Scale With Atypical Depression Supplement (SIGH-ADS), the Mania Rating Scale and the Pittsburgh Sleep Quality Index to assess symptoms weekly. Remission was defined as having SIGH-ADS score of ≤8.

Patients in both treatment groups had moderate depression and no hypomanic or manic symptoms at baseline. Patients treated with bright white light, compared with those in the placebo light group, had a significantly higher remission rate (68.2 percent vs 22.2 percent; adjusted odds ratio, 12.6) at weeks 4‒6 and significantly lower depression scores (9.2 vs 14.9; adjusted β, ‒5.91) at the endpoint visit.

There were no mood polarity switches seen among patients. Both groups had improved sleep quality, which did not show significant difference between them.

“Patients with bipolar disorder have recurrent major depression, residual mood symptoms and limited treatment options,” the investigators said.

In one study, depression during pregnancy was improved significantly more with bright white light treatment for 5 weeks than with placebo dim red light, providing evidence that light therapy, a simple, cost-effective antidepressant modality with minimal side effects for the mother and no known risk for the unborn child, may be a beneficial nonpharmacologic strategy in this situation. [J Clin Psychiatry 2011;72:986-993]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 2 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Jairia Dela Cruz, 6 days ago
Male smokers under the age of 50 years are at risk of developing ischaemic stroke, and this risk increases with the number of cigarettes smoked daily, according to data from the Stroke Prevention in Young Men Study.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.